<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04229693</url>
  </required_header>
  <id_info>
    <org_study_id>UHC_NAMU</org_study_id>
    <nct_id>NCT04229693</nct_id>
  </id_info>
  <brief_title>Cerebrospinal Fluid Proteom in Dependence of Intranasal Breast Milk</brief_title>
  <acronym>NAMU</acronym>
  <official_title>Proteomics of Cerebrospinal Fluid of Preterm Infants With Posthemorrhagic Hydrocephalus With Focus on Intranasal Breast Milk.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Cologne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of the cerebrospinal fluid proteom in preterm infants with posthemorrhagic
      hydrocephalus in our neonatology center with analysis for modulation of proteom in dependence
      of breastmilk feeding and way of application such as via gavage tube, oral or nasal
      application.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since the nasal route might be highly effective for neurotrophins and other growth factors
      the cerebrospinal fluid will be investigated using mass spectrometry to identify modulating
      effects of intranasal breast milk application on the cerebrospinal fluid proteom.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 7, 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebrospinal fluid proteom</measure>
    <time_frame>weeks</time_frame>
    <description>Cerebrospinal fluid analysis using mass spectrometry including proteomic analysis for differences in dependence of intranasal breast milk application</description>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hydrocephalus in Infants</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>no intervention, only observational.</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cerebrospinal fluid samples which are collected after routine drainage via ventricle
      reservoir
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All preterm infants at our neonatologic center with hydrocephalus in need of drainage are
        eligible.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  preterm infant with hydrocephalus and regular drainage

        Exclusion Criteria:

          -  Inborn error of metabolism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Titus Keller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cologne, Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Titus Keller, MD</last_name>
    <phone>0049 221 4449</phone>
    <email>titus.keller@uk-koeln.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Angela Kribs, MD</last_name>
    <phone>0049 221 5998</phone>
    <email>angela.kribs@uk-koeln.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Neonatology at the University Hospital of Cologne</name>
      <address>
        <city>Cologne</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Titus Keller, MD</last_name>
      <phone>0049 221 478 5998</phone>
      <email>titus.keller@uk-koeln.de</email>
    </contact>
    <contact_backup>
      <last_name>Angela Kribs, MD</last_name>
      <phone>0049 221 478 5064</phone>
      <email>angela.kribs@uk-koeln.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Keller T, KÃ¶rber F, Oberthuer A, Schafmeyer L, Mehler K, Kuhr K, Kribs A. Intranasal breast milk for premature infants with severe intraventricular hemorrhage-an observation. Eur J Pediatr. 2019 Feb;178(2):199-206. doi: 10.1007/s00431-018-3279-7. Epub 2018 Nov 1.</citation>
    <PMID>30386923</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 13, 2020</study_first_submitted>
  <study_first_submitted_qc>January 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>February 7, 2020</last_update_submitted>
  <last_update_submitted_qc>February 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Cologne</investigator_affiliation>
    <investigator_full_name>Titus Keller, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocephalus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

